Associate Medical Advisor

We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs. Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity, and respect for people.

If you are interesting in being considered for employment with our company, please review the following opportunity in Eli Lilly South East Europe:

Associate Medical Advisor

South-East Europe

Key Responsibilities:

• Business/customer support (pre and post product launch support)
• Scientific Data Dissemination/Exchange
• Clinical Research/Trial Execution and Support in partnership with SEE staff or contracted organizations
• Regulatory Support Activities
• Scientific/Technical Expertise and continued development
• Reference: Btcm5wIgIRhtTTVdyg0gWq1HKYSd3WXjSk4q0XOUj75XBrlqQ1qCU97st1YC0_mz

The primary responsibilities are mainly related to late-phase and marketed compounds but can also include early phase trials.

Minimum Requirements:

• Medical Doctor, specialty in Endocrinology (Diabetes clinical experience is a plus)
• Clinical Research or pharmaceutical medicine experience preferred
• Knowledge of drug development process relevant to country/region preferred
• Excellent English communication (written and verbal), interpersonal, organizational and negotiation skills
• Ability to influence other (both cross-functionally and within the function) in order to create a positive working environment
• Excellent teamwork skills

The position requires about 40% international travel in the South East European area.

We are offering:

• Competitive package
• Challenging and responsible job in a talented team and friendly working environment.

Please send your CV and application letter, in English, by 18.05.2012.